Evidence map›Paper›PMID 19843337›Full record

ArticleBMC gastroenterology2009

Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.

Nikolaus Möckelmann, Witigo von Schönfels, Stephan Buch, Oliver von Kampen, Bence Sipos, Jan Hendrik Egberts, Philip Rosenstiel, Andre Franke, Mario Brosch, Sebastian Hinz and 9 more

Open access · goldAbstract readComparative StudyMulticenter Study
In one paragraph

Article in BMC gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Cancers · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. NOD2 mutations and colorectal cancer - Where do we stand?World journal of gastrointestinal surgery · 2016
    Review
  13. The role of NOD1/CARD4 and NOD2/CARD15 genetic variations in lung cancer risk.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  14. CD93 gene polymorphism is associated with disseminated colorectal cancer.International journal of colorectal disease · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Nikolaus MöckelmannDepartment of General Internal Medicine Christian-Albrechts-University, Kiel, Germany. nikomoeckelmann@googlemail.com
Witigo von Schönfels
Stephan Buch
Oliver von Kampen
Bence Sipos
Jan Hendrik Egberts
Philip Rosenstiel
Andre Franke
Mario Brosch
Sebastian Hinz
Christian Röder
Holger Kalthoff
Ulrich R Fölsch
Michael Krawczak
Stefan Schreiber
Clemens Dieter Bröring
Jürgen Tepel
Clemens Schafmayer
Jochen Hampe
Kiel University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVariation in genes involved in the innate immune response may play a role in the predisposition to colorectal cancer (CRC). Several polymorphisms of the CARD15 gene (caspase activating recruitment domain, member 15) have been reported to be associated with an increased susceptibility to Crohn disease. Since the CARD15 gene product and other CARD proteins function in innate immunity, we investigated the impact of germline variation at the CARD4, CARD8 and CARD15 loci on the risk for sporadic CRC, using a large patient sample from Northern Germany.

methodsA total of 1044 patients who had been operated with sporadic colorectal carcinoma (median age at diagnosis: 59 years) were recruited and compared to 724 sex-matched, population-based control individuals (median age: 68 years). Genetic investigation was carried out following both a coding SNP and haplotype tagging approach. Subgroup analyses for N = 143 patients with early manifestation of CRC (<or=50 age at diagnosis) were performed for all CARD loci and subgroup analyses for diverse age strata were carried out for CARD15 mutations R702W, G908R and L1007fs. In addition, all SNPs were tested for association with disease presentation and family history of CRC.

resultsNo significant differences were observed between the patient and control allelic or haplotypic spectra of the three genes under study for the total cohort (N = 1044 patients). None of the analysed SNPs was significantly associated with either tumour location or yielded significant association in the familial or non-familial CRC patient subgroups. However, in a patient subgroup (<or=45 age at diagnosis) with early disease manifestation the mutant allele of CARD15 R702W was found to be significantly associated with disease susceptibility (9.7% in cases vs 4.6% in controls; P(allelic) = 0.008, P(genotypic) = 0.0008, OR(allelic) = 2.22 (1.21-4.05) OR(ressessive) = 21.9 (1.96-245.4).

conclusionVariation in the innate immunity genes CARD4, CARD8 and CARD15 is unlikely to play a major role in the susceptibility to CRC in the German population. But, we report a significant disease contribution of CARD15 for CRC patients with very early disease manifestation, mainly driven by variant R702W.

Indexed as

MutationAdolescentAdultAgedAged, 80 and overApoptosisCARD Signaling Adaptor ProteinsColorectal NeoplasmsDNA, NeoplasmFemaleGenetic Predisposition to DiseaseHumansImmunity, InnateMaleMiddle AgedNeoplasm ProteinsCARD8 protein, humanCARD Signaling Adaptor ProteinsDNA, NeoplasmNeoplasm ProteinsNOD1 protein, humanNod1 Signaling Adaptor ProteinNOD2 protein, humanNod2 Signaling Adaptor Protein

Identifiers

PMID19843337
PMCPMC2776017
OpenAlexW2155102185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.